Oncotelic Therapeutics, Inc. (OTLC) SEC Filings — 2025
14 SEC filings for Oncotelic Therapeutics, Inc. (OTLC) in 2025.
Filings
- Oncotelic Therapeutics, Inc. 8-K Filing — 8-K · Dec 30, 2025
- Oncotelic Therapeutics, Inc. 8-K Filing — 8-K · Dec 23, 2025
- Oncotelic Files S-1/A for Mast Hill's 20.1% Share Resale Amid Going Concern Doubts — S-1/A · Dec 22, 2025
- Oncotelic Therapeutics Files 8-K on Agreements — 8-K · Dec 9, 2025
- Oncotelic S-1 Reveals Mast Hill to Resell 39.1% of Shares; Going Concern Doubts Persist — S-1 · Nov 21, 2025
- Oncotelic Narrows Losses, Boosts Cash Amid R&D Focus — 10-Q · Nov 17, 2025
- Oncotelic Therapeutics Files 8-K — 8-K · Oct 22, 2025
- Oncotelic Narrows Losses, Posts Q2 Profit Amidst R&D Focus — 10-Q · Aug 13, 2025
- Oncotelic Therapeutics Reports Material Agreement and Equity Sales — 8-K · Aug 12, 2025
- Oncotelic Therapeutics, Inc. 8-K Filing — 8-K · Aug 6, 2025
- Oncotelic Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Oncotelic Therapeutics Files 2024 10-K — 10-K · Apr 15, 2025
- Oncotelic Therapeutics, Inc. 8-K Filing — 8-K · Mar 25, 2025
- Oncotelic Therapeutics Files 8-K — 8-K · Jan 2, 2025